ALDEYRA THERAPEUTICS, INC. Basic Shares Outstanding (Weighted Average)
ALDEYRA THERAPEUTICS, INC. (ALDX) reported Basic Shares Outstanding (Weighted Average) of 60.32 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-06
- ALDEYRA THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 60.32M shares, a 0.46% increase year-over-year.
- ALDEYRA THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 60.32M shares, a 0.72% increase year-over-year.
- ALDEYRA THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 60.16M shares, a 0.98% increase year-over-year.
- ALDEYRA THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 60.13M shares, a 1.00% increase year-over-year.
- ALDEYRA THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 60.06M shares, a 0.96% increase from fiscal 2024.
- ALDEYRA THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 59.48M shares, a 0.92% increase from fiscal 2023.
- ALDEYRA THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 58.94M shares, a 0.92% increase from fiscal 2022.
- ALDEYRA THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 58.41M shares, a 8.07% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 60.32M shares 10-Q · filed 2026-08-06 | 60.32M shares 10-Q · filed 2026-08-06 | 60.27M shares derived: average of 3 quarters · filed 2026-08-06 | 60.23M shares derived: average of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | 60.32M shares 10-Q · filed 2026-05-07 | 60.24M shares derived: average of 2 quarters · filed 2026-05-07 | 60.20M shares derived: average of 3 quarters · filed 2026-05-07 | 60.16M shares derived: average of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | 60.16M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | 60.15M shares derived: average of 2 quarters · filed 2026-02-27 | 60.11M shares derived: average of 3 quarters · filed 2026-08-06 | 60.06M shares 10-K · filed 2026-02-27 | |
| 2025-09-30 | 60.13M shares 10-Q · filed 2025-11-05 | 60.09M shares derived: average of 2 quarters · filed 2026-08-06 | 60.02M shares 10-Q · filed 2025-11-05 | 59.91M shares derived: average of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | 60.05M shares 10-Q · filed 2026-08-06 | 59.97M shares 10-Q · filed 2026-08-06 | 59.84M shares derived: average of 3 quarters · filed 2026-08-06 | 59.76M shares derived: average of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | 59.89M shares 10-Q · filed 2026-05-07 | 59.73M shares derived: average of 2 quarters · filed 2026-05-07 | 59.67M shares derived: average of 3 quarters · filed 2026-05-07 | 59.60M shares derived: average of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | 59.58M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | 59.55M shares derived: average of 2 quarters · filed 2026-02-27 | 59.51M shares derived: average of 3 quarters · filed 2026-02-27 | 59.48M shares 10-K · filed 2026-02-27 | |
| 2024-09-30 | 59.53M shares 10-Q · filed 2025-11-05 | 59.47M shares derived: average of 2 quarters · filed 2025-11-05 | 59.45M shares 10-Q · filed 2025-11-05 | 59.39M shares derived: average of 4 quarters · filed 2025-11-05 | |
| 2024-06-30 | 59.41M shares 10-Q · filed 2025-08-07 | 59.41M shares 10-Q · filed 2025-08-07 | 59.34M shares derived: average of 3 quarters · filed 2025-08-07 | 59.25M shares derived: average of 4 quarters · filed 2025-08-07 | |
| 2024-03-31 | 59.41M shares 10-Q · filed 2025-05-14 | 59.31M shares derived: average of 2 quarters · filed 2025-05-14 | 59.20M shares derived: average of 3 quarters · filed 2025-05-14 | 59.10M shares derived: average of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | 59.20M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | 59.09M shares derived: average of 2 quarters · filed 2025-02-28 | 58.99M shares derived: average of 3 quarters · filed 2025-02-28 | 58.94M shares 10-K · filed 2025-02-28 | |
| 2023-09-30 | 58.99M shares 10-Q · filed 2024-11-07 | 58.89M shares derived: average of 2 quarters · filed 2024-11-07 | 58.86M shares 10-Q · filed 2024-11-07 | 58.78M shares derived: average of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | 58.79M shares 10-Q · filed 2024-08-01 | 58.79M shares 10-Q · filed 2024-08-01 | 58.72M shares derived: average of 3 quarters · filed 2024-08-01 | 58.65M shares derived: average of 4 quarters · filed 2024-08-01 | |
| 2023-03-31 | 58.79M shares 10-Q · filed 2024-05-02 | 58.68M shares derived: average of 2 quarters · filed 2024-05-02 | 58.60M shares derived: average of 3 quarters · filed 2024-05-02 | 58.53M shares derived: average of 4 quarters · filed 2024-05-02 | |
| 2022-12-31 | 58.56M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | 58.51M shares derived: average of 2 quarters · filed 2024-03-07 | 58.44M shares derived: average of 3 quarters · filed 2024-03-07 | 58.41M shares 10-K · filed 2024-03-07 | |
| 2022-09-30 | 58.46M shares 10-Q · filed 2023-11-03 | 58.38M shares derived: average of 2 quarters · filed 2023-11-03 | 58.35M shares 10-Q · filed 2023-11-03 | 58.29M shares derived: average of 4 quarters · filed 2023-11-03 | |
| 2022-06-30 | 58.30M shares 10-Q · filed 2023-08-03 | 58.30M shares 10-Q · filed 2023-08-03 | 58.23M shares derived: average of 3 quarters · filed 2023-08-03 | 58.18M shares derived: average of 4 quarters · filed 2023-08-03 | |
| 2022-03-31 | 58.30M shares 10-Q · filed 2023-05-04 | 58.20M shares derived: average of 2 quarters · filed 2023-05-04 | 58.14M shares derived: average of 3 quarters · filed 2023-05-04 | 57.17M shares derived: average of 4 quarters · filed 2023-05-04 | |
| 2021-12-31 | 58.10M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | 58.06M shares derived: average of 2 quarters · filed 2023-03-09 | 56.80M shares derived: average of 3 quarters · filed 2023-03-09 | 54.04M shares 10-K · filed 2023-03-09 | |
| 2021-09-30 | 58.02M shares 10-Q · filed 2022-11-10 | 56.15M shares derived: average of 2 quarters · filed 2022-11-10 | 52.69M shares 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | 54.28M shares 10-Q · filed 2022-08-05 | 49.98M shares 10-Q · filed 2022-08-05 | |||
| 2016-03-31 | 9.71M shares 10-Q · filed 2016-05-09 | 9.72M shares derived: average of 2 quarters · filed 2016-05-09 | 9.72M shares derived: average of 3 quarters · filed 2016-05-09 | 9.39M shares derived: average of 4 quarters · filed 2016-05-09 | |
| 2015-12-31 | 9.72M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | 9.72M shares derived: average of 2 quarters · filed 2016-03-30 | 9.28M shares derived: average of 3 quarters · filed 2016-03-30 | 8.63M shares 10-K · filed 2016-03-30 | |
| 2015-09-30 | 9.71M shares 10-Q · filed 2015-11-13 | 9.06M shares derived: average of 2 quarters · filed 2015-11-13 | 8.27M shares 10-Q · filed 2015-11-13 | 7.59M shares derived: average of 4 quarters · filed 2016-05-09 | |
| 2015-06-30 | 8.40M shares 10-Q · filed 2015-08-14 | 7.54M shares 10-Q · filed 2015-08-14 | 6.88M shares derived: average of 3 quarters · filed 2016-05-09 | 6.55M shares derived: average of 4 quarters · filed 2016-05-09 | |
| 2015-03-31 | 6.67M shares 10-Q · filed 2016-05-09 | 6.13M shares derived: average of 2 quarters · filed 2016-05-09 | 5.94M shares derived: average of 3 quarters · filed 2016-05-09 | 5.39M shares derived: average of 4 quarters · filed 2016-05-09 | |
| 2014-12-31 | 5.58M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | 5.58M shares derived: average of 2 quarters · filed 2016-03-30 | 4.96M shares derived: average of 3 quarters · filed 2016-03-30 | 3.82M shares 10-K · filed 2016-03-30 | |
| 2014-09-30 | 5.57M shares 10-Q · filed 2015-11-13 | 5.57M shares 10-Q · filed 2014-11-12 | 4.65M shares derived: average of 2 quarters · filed 2015-11-13 | 3.23M shares 10-Q · filed 2015-11-13 | 2.49M shares derived: average of 4 quarters · filed 2015-11-13 |
| 2014-06-30 | 3.74M shares 10-Q · filed 2015-08-14 | 2.04M shares 10-Q · filed 2015-08-14 | 1.46M shares derived: average of 3 quarters · filed 2015-08-14 | 1.18M shares derived: average of 4 quarters · filed 2015-08-14 | |
| 2014-03-31 | 327.37K shares 10-Q · filed 2015-05-14 | 328.08K shares derived: average of 2 quarters · filed 2015-05-14 | 324.51K shares derived: average of 3 quarters · filed 2015-05-14 | 321.99K shares derived: average of 4 quarters · filed 2015-05-14 | |
| 2013-12-31 | 328.80K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-23 | 323.09K shares derived: average of 2 quarters · filed 2015-03-23 | 320.20K shares derived: average of 3 quarters · filed 2015-03-23 | 318.43K shares 10-K · filed 2015-03-23 | |
| 2013-09-30 | 317.38K shares 10-Q · filed 2014-11-12 | 315.90K shares derived: average of 2 quarters · filed 2014-11-12 | 314.97K shares 10-Q · filed 2014-11-12 | ||
| 2013-06-30 | 314.42K shares 10-Q · filed 2014-08-07 | 314.42K shares 10-Q · filed 2014-08-07 | |||
| 2013-03-31 | 314.42K shares 10-Q · filed 2014-06-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |